Oncology Institute Inc reports results for the quarter ended in December - Earnings Summary

Oncology Institute

09/03/2023 23:48

* Oncology Institute Inc  TOI.OQ  reported a quarterly
adjusted
loss of 25 cents​​ per share for the quarter ended in December.
The mean expectation of two analysts for the quarter was for a
loss of 18 cents per share.
    * Revenue was $71.42 million​; analysts expected $64.75
million. 
    * Oncology Institute Inc's reported EPS for the quarter was
a loss
of 11 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Oncology Institute Inc shares had fallen by 14.5% this
quarter.
    * The company reported a quarterly loss of $9.5 million.
    * Wall Street's median 12-month price target for Oncology
Institute Inc is $6.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 9 at 11:48 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.18          -0.25          Missed
 Sep. 30 2022      -0.18          -0.25          Missed